Showing results (171-180 of 654) with videos related to

Sort By:
Pageof 66
Molecules (Basel, Switzerland)|August 14, 2025
The Pharmacological Evidences for the Involvement of AhR and GPR35 Receptors in Kynurenic Acid-Mediated Cytokine and Chemokine Secretion by THP-1-Derived MacrophagesKatarzyna Sawa-Wejksza, Jolanta Parada-Turska, Waldemar Turski
Acta Neurologica Scandinavica|May 22, 2003
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosisJ Iłzecka, T Kocki, Z Stelmasiak, et al.
Magnetic Resonance in Medicine|April 1, 1992
ECG-optimized phase contrast line-scanned MR angiographyF R Korosec, C A Mistretta, P A Turski
Annals of Agricultural and Environmental Medicine : AAEM|July 9, 2011
Content of transfluthrin in indoor air during the use of electro-vaporizersTeresa Nazimek, Magdalena Wasak, Wojciech Zgrajka, et al.
Magnetic Resonance in Medicine|October 28, 2021
Simultaneous 3D-TOF angiography and 4D-flow MRI with enhanced flow signal using multiple overlapping thin slab acquisition and magnetization transferDahan Kim, Laura Eisenmenger, Patrick Turski, et al.
Brain Research|December 3, 1986
Motor actions of excitatory amino acids and their antagonists within the rat ventromedial thalamic nucleusT Klockgether, L Turski, M Schwarz, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 1, 1995
Basilar artery dolichoectasia. Review of the literature and six patients studied with magnetic resonance angiographyR L Levine, P A Turski, T M Grist
Magnetic Resonance Imaging Clinics of North America|November 4, 1998
Basic concepts of functional magnetic resonance imaging and arteriovenous malformationsTurski, Cordes, Mock, et al.
Neuroscience Letters|May 18, 1990
Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in miceL Turski, K Bressler, T Klockgether, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxalineL Turski, P Jacobsen, T Honoré, et al.
Pageof 66